Tempus extends data license with Recursion; adds RNA model license
Tempus AI said it extended its data license agreement with Recursion Pharmaceuticals and entered a new agreement under which Tempus will license Recursion’s RNA Foundation Model.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.